By ANGUS McNEICE in London | China Daily Global | Updated: 2021-02-04 09:28 Share CLOSE A vial of the Oxford University/AstraZeneca COVID-19 vaccine is seen at the Lochee Health Centre in Dundee, Scotland, Britain, Jan 4, 2021. [Photo/Agencies]
Effect of single dose also lasts longer than previously thought, study finds
One dose of the novel coronavirus vaccine produced by AstraZeneca and the University of Oxford provides protection from the virus for at least three months, according to new analysis that also found the jab inhibits transmission.
Announcing the dual wins, Oxford University scientists said those who have received an injection are therefore less likely to spread the virus to others, a fact that had not previously been proven by research.
Coronavirus updates LIVE: Matt Hancock promises strong border action in fight against variants chroniclelive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chroniclelive.co.uk Daily Mail and Mail on Sunday newspapers.
UK Health Secretary Refuses To Confirm Date For Quarantine Hotels
Wed, 3rd Feb 2021 10:45
(Alliance News) - UK Health Secretary Matt Hancock has refused to confirm that quarantine hotels for international arrivals will open this month.
The UK government announced the policy aimed at limiting the spread of new coronavirus strains last week, but has not revealed when it will be implemented.
Hancock was asked by LBC if the scheme will be launched by the end of February.
The cabinet minister replied: We ll set out more details of that when we re ready to, but you ve seen that we re perfectly prepared to take very tough action if that s what s needed.
LONDON: The rollout of COVID-19 vaccines could eventually reduce the severity of the virus to something akin to the common cold, a leading UK scientist has said.
Prof. Andrew Pollard, head of the Oxford team of scientists who produced a vaccine in partnership with AstraZeneca, said he expects the virus to gradually become more easy to transmit through natural evolution, but less likely to cause fatalities.
He added that emerging strains, such as the so-called Kent variant (B117), showed that the virus is “trying to escape from human immunity, whether from vaccines or from infection.”
But he expressed hope that data would soon show how well the Oxford vaccine is performing against COVID-19 and the more virulent strains.